Latest News

Behind the Breakthrough Podcast Episode 9 - Pioneering research by UHN’s Dr. Kristin Musselman is designed to get spinal cord injured patients mobile

December 06, 2019 /in Latest News

Air Date: December 3, 2019 | Length: 30:22

Dr. Kristin Musselman is a pioneer in research designed to get patients with partial spinal cord injury up and walking again. She joins UHN’s Behind the Breakthrough podcast to talk about her latest research, how it relies heavily on patient input, and the satisfaction of seeing those same patients try new strategies to regain mobility and maintain their balance.

Get this episode:​

...

Read More

UHN Spin-off MolecuLight Receives FDA 510(k) Clearance for its i:X® Handheld Fluorescence Imaging Device for Wound Management

December 05, 2019 /in Latest News

New FDA Approval Extends Label to Including the i:X’s Detection of Bacteria and Digital Wound Measurement

TORONTO, Canada – (December 5, 2019) MolecuLight Inc., the world’s leader in handheld fluorescence imaging for real-time visualization of fluorescence in wounds, has received FDA 510(k) clearance for its i:X® handheld fluorescence imaging device for use in the detection of wounds containing bacteria. This FDA 510(k) clearance is an expansion of the original de novo clearance for the MolecuLight i:X platform, granted on August 14, 2018. The MolecuLight i:X enables real time point-of-...

Read More

Behind the Breakthrough Podcast Episode 8 - Reversing blindness and the serendipity of science, with Dr. Valerie Wallace

December 02, 2019 /in Latest News

Air Date: November 26, 2019 | Length: 35:04

Dr. Valerie Wallace is on a mission to reverse blindness. The award-winning senior scientist and co-director of the Donald K. Johnson Eye Institute at UHN’s Krembil Research Institute sits down with Behind the Breakthrough to discuss the serendipity of science, the curiosity that drives her and the changing landscape of women in STEM.

Get this episode:​

...

Read More

Behind the Breakthrough Podcast Episode 7 – Repairing broken hearts with stem cells, with Dr. Michael Laflamme

December 02, 2019 /in Latest News

Air Date: November 19, 2019 | Length: 28:22

In this episode of Behind the Breakthrough, we hear from cardiac pathologist and award-winning principal investigator at the McEwen Stem Cell Institute Dr. Michael Laflamme. His mission: to restore the function of injured hearts by replacing scar tissue with healthy heart muscle cells made from stem cells.

Get this episode:​

...

Read More

TDC is Hiring! Licensing and Commercialization Professional, KITE

November 21, 2019 /in Latest News

University Health Network (UHN) is looking for an experienced professional to fill the key role of Licensing & Commercialization Professional in our Technology Development and Commercialization Department (TDC).

Learn more, and apply here

UHN Remains Canada’s Top Research Hospital!

November 18, 2019 /in Latest News

11/14/2019

Collage of UHN buildings

UHN spent $362.8 million on research activities in the last fiscal year, a 3.6 per cent increase from the previous year, to rank first on the RE$EARCH Infosource Inc. list of Canada’s Top Research Hospitals. (Graphic: UHN)

For the ninth year in a row, UHN tops RE$EARCH Infosource Inc.’s list of Canada’s Top 40 Research Hospitals. The list has been compiled annually since 2011. 

In the last fiscal year, UHN spent $362.8 million on research activities – representing 3.6 per cent more than the previous year, and approximately 17.5 per cent of its total hospital spending.  

The...

Read More

Behind the Breakthrough Podcast Episode 6 – Overcoming ‘imposter syndrome’ and helping the elderly live well, with Dr. Jennifer Campos

November 15, 2019 /in Latest News

Air Date: November 12, 2019 | Length: 40:02

Growing up, the death of Dr. Jenny Campos’ grandfather from a preventable fall while carrying groceries up a flight of stairs shook her family to the core. Today, it is the driving force behind her research in falls and driving collision prevention in the elderly. By simulating real life challenges in Toronto Rehabilitation Institute’s renowned Challenging Environment Assessment Lab (CEAL), Dr. Campos is finding ways to help older adults live well.

Get this episode:​

...

Read More

Behind the Breakthrough Podcast Episode 5 – Meet the cancer codebreaker, Dr. Mathieu Lupien

November 15, 2019 /in Latest News

Air Date: November 5, 2019 | Length: 47:38

In the battle to defeat cancer, award-winning UHN researcher Dr. Mathieu Lupien is a modern-day version of the Bletchley Park World War Two codebreakers. Dr. Lupien searches the human genome, trying to crack the origin of how and why cancer starts. He knows deciphering that enigmatic code is one of the keys that will lead to a cure for cancer. Dr. Lupien also talks about the Terry Fox loonie he carries in his pocket at all times as a reminder of the commitment and importance of the work done in his lab, how a line in a TV show he watched as a child in Quebec has fuelled his research career,” and his advice for kids who want to go into science.

Get this episode:​

...

Read More

Behind the Breakthrough Podcast Episode 4 – Robotics, rehabilitation therapy and learning from failure, with Dr. Milos Popovic

November 15, 2019 /in Latest News

Episode 4 – Robotics, rehabilitation therapy and learning from failure, with Dr. Milos Popovic

Air Date: October 29, 2019 | Length: 32:03

We sit down with Dr. Milos Popovic to hear about his transformational shift from aerospace engineering to rehabilitation research, and how it led to his invention of a medical device that delivers electrical stimulation to restore upper limb mobility to people with paralysis caused by spinal cord injury and stroke. Originally from Belgrade, Dr. Popovic shares how he narrowly escaped Yugoslavia’s brutal civil war as military soldiers banged on doors looking for conscripts.

Get this episode:​

...

Read More

Behind the Breakthrough Podcast Episode 3 – Challenging the meaning of palliative care, with Dr. Camilla Zimmermann

November 15, 2019 /in Latest News

Air Date: October 22, 2019 | Length: 43:20

Dr. Camilla Zimmermann talks about how her research has helped change the practice of palliative care from end-of-life care to a more wholistic approach that answers the question, “What do you want to do with the rest of your life?” Dr. Zimmermann also reveals how the death of her parents when she was a teenager shaped her career, her initial reluctance to admit to colleagues her desire to be a palliative care specialist, and how stigma still hangs on the concept of what is palliative care.

Get this episode:​

...

Read More

Behind the Breakthrough Podcast Episode 2 – Chronic pain and scientific baseball, with Dr. Karen Davis

November 15, 2019 /in Latest News

Air Date: October 15, 2019 | Length: 34:56

In this episode, neuroscientist Dr. Karen Davis talks to us about pain. What is it? Can we predict it? What does personality-type have to do with it? While the complexity of pain is still not well understood, the uncertainty doesn’t stop Dr. Davis and her team. “We all have doubts,” she says. “But what drives most of us is a very fundamental curiosity … and the more we interact with patients the more it motivates us to think outside the box.”

Get this episode:​

...

Read More

UHN Launches Behind the Breakthrough Podcast

October 09, 2019 /in Latest News

Behind the Breakthrough: ​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​ A podcast about the people behind the world-leading research at UHN

UHN Podcast Behind the Breakthrough Cover

UHN is excited to launch a new podcast series called "Behind the Breakthrough". Featuring interviews with scientists from across UHN, the podcast reveals the motivation behind their pursuit of answers to important questions—what is the cure for Alzheimer disease? How can we help prevent the elderly from falling? Will stem cells regenerate damaged hearts? How does cancer start?

Episodes present intimate, one-on-one conversations with UHN scientists...

Read More

UHN Spin-off Technology, Moleculight's i:X, is Featured at the Largest Canadian Wound Care Conference

October 07, 2019 /in Latest News

Results from Clinical Studies using MolecuLight i:X® Fluorescence Imaging System
 Featured Prominently at the Wounds Canada 2019 Annual Conference

October 4, 2019

Point-of-Care Fluorescence Imaging for Chronic Wounds and its Significant Clinical Benefits are Featured at the Largest Canadian Wound Care Conference in 5 Clinical Talks and Posters

NIAGARA FALLS, Canada and TORONTO, Canada – (October 4, 2019) MolecuLight Inc., the world’s leader in handheld fluorescence imaging for real-time visualization of bacteria for chronic wounds, and its i:X point-of-care fluorescence imaging device are featured prominently at the Wounds Canada 2019 Annual Conference. The conference, which is the...

Read More

First patients treated with machine learning generated plans as part of an evaluation study at UHN's Princess Margaret Cancer Centre

September 17, 2019 /in Latest News

 

The first-ever patient radiation therapy treatments generated with machine learning in the RayStation® treatment planning system (TPS) have been conducted. Patients with localized prostate cancer are being treated with this unique technology at the Princess Margaret Cancer Centre in Toronto, Canada, as part of a comprehensive evaluation study.

RaySearch released the machine learning features in RayStation 8B* in late December 2018. This ground-breaking technology has been developed by RaySearch’s in-house machine learning department in collaboration with researchers at UHN's Princess Margaret Cancer Centre and Techna Institutes, crystalizing years of cutting-edge research led by UHN medical physicist Dr. Tom Purdie and UHN computer scientist Dr. Chris McIntosh. The features represent the first applications of machine learning in a TPS on the radiation...

Read More

UHN Research's Gordon Keller Receives Ogawa-Yamanaka Stem Cell Prize

September 05, 2019 /in Latest News

World-renowned stem cell scientist Gordon Keller, PhD, is the recipient of the 2019 Ogawa-Yamanaka Stem Cell Prize awarded by the Gladstone Institutes for his work with pluripotent stem cells.

Dr. Keller is the Director of the McEwen Stem Cell Institute at the University Health Network, Senior Scientist at Princess Margaret Cancer Centre and Professor in the department of medical biophysics at the University of Toronto. He was recognized for his contributions to efficient lineage-specific differentiation of human pluripotent stem cells into a myriad of cell types, enabling disease modeling and...

Read More

photonamic Acquires Oncology Business from UHN Spin-off MolecuLight

August 14, 2019 /in Latest News

          

photonamic GmbH & Co. KG (Germany) Acquires the Oncology Business from MolecuLight Inc. (Canada)

August 14th, 2019  photonamic GmbH & Co. KG (Head office: Pinneberg, Germany; CEO: Ulrich Kosciessa, Ph.D.) (“photonamic”), a subsidiary of SBI Holdings, Inc. (Head office: Minato-ku,Tokyo; Representative Director, President and CEO: Yoshitaka Kitao) is engaged in the business of pharmaceutical development of 5-aminolevulinic acid (“5-ALA”) (*) hereby announces the acquisition of the Oncology Business of MolecuLight Inc. (Head office: Toronto, Canada; CEO: Anil Amlani) (“MolecuLight”), through its newly...

Read More

TDC Launches Alliance Management at UHN

August 13, 2019 /in Latest News

Christina von Gemmingen, launches Alliance Management for UHN as Licensing Professional/Alliance Manager at TDC

 

Technology Development and Commercialization is pleased to announce the arrival of Christina von Gemmingen, who launches the function of Alliance Management for UHN as Licensing Professional/Alliance Manager at TDC.

The launch of an Alliance Management function at TDC brings a new level of sophistication to the management of partner relationships between industry and our research community. In this role, Christina will maintain a strategic overview of contracts with our industry partners, and help ensure the success of these partnerships by aligning internally and externally with stakeholders on all...

Read More

UHN Spin-out BlueRock Therapeutics Aquired by Bayer in US$1 Billion Deal

August 08, 2019 /in Latest News
Bayer acquires BlueRock Therapeutics to build leading position in cell therapy
– Implied total company value of up to USD 1 billion, inclusive of 40.8 percent stake currently held by Bayer
– Initial focus in neurology, cardiology, and immunology with start of first clinical program in Parkinson’s disease expected later this year
– BlueRock Therapeutics to continue to operate as an independent company 

Berlin/Cambridge, Mass., Aug. 8, 2019 – Bayer AG and BlueRock Therapeutics today announced an agreement under which Bayer will fully acquire BlueRock Therapeutics, a privately held US-headquartered biotechnology company focused on developing engineered cell therapies in the fields of neurology, cardiology and immunology, using a proprietary induced pluripotent stem cell (iPSC) platform....

Read More

UHN's Dr. Rob Rottapel’s Research Tools Reach the Global Research Community

August 08, 2019 /in Latest News

UHN is pleased to announce a successful licensing deal with EMD Millipore which will provide for UHN Princess Margaret Cancer Centre Senior Scientist Rob Rottapel’s research tools to the global research community. The research tools can be found at:

MABC1096, Anti-GEF-H1, clone 3C5       

http://www.emdmillipore.com/US/en/product/Anti-GEF-H1-Antibody-clone-3C5,MM_NF-MABC1096-25UG

http://www.emdmillipore.com/US/en/product/Anti-GEF-H1-Antibody-clone-3C5,MM_NF-MABC1096-100UG

 

MABC1097, Anti-GEF-H1, clone 14B11

...

Read More

Princess Margaret Cancer Centre Innovation Acceleration Fund Announces New Recipients of Funding in Support of Early Stage Technology Development

June 20, 2019 /in Latest News

The Princess Margaret Cancer Foundation’s Innovation Accelerator Fund (IAF) Leadership Board has announced the first three funded projects of 2019.  The IAF was established by The Princess Margaret Cancer Foundation in collaboration with University Health Network’s Technology Development and Commercialization Office in January 2016 to help investigators at the Princess Margaret Cancer Centre accelerate their early-stage research discoveries towards commercialization.  The fund provides a maximum of $250,000 per proposal, helping to take novel technologies from bench-to-bedside. The three selected projects of this round include:

 

Preclinical Testing of Novel TCR-based Treatment for Cancer

Dr. Naoto Hirano, a Senior Scientist at the Princess Margaret Cancer Centre, was selected for an additional round of IAF funding to support the...

Read More